35 studies found for:    " July 24, 2013":" August 23, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" July 24, 2013":" August 23, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (35 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: EVG;   Drug: Background regimen
2 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
3 Unknown  Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire
Condition: HIV Infection
4 Unknown  Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
5 Recruiting IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
6 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
7 Active, not recruiting A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir/abacavir/lamivudine FDC;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine FDC
8 Completed
Has Results
A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
Condition: HIV Infections
Interventions: Drug: Raltegravir (ISENTRESS™);   Drug: MAALOX (MAL)
9 Unknown  Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV
Interventions: Drug: Pegylated interferon alpha-2a;   Drug: Ribavirin;   Drug: Boceprevir
10 Recruiting RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users
Conditions: HIV/AIDS;   Stimulant Use Disorders
Interventions: Behavioral: Affect Regulation Treatment to Enhance Meth Intervention Success (ARTEMIS);   Behavioral: Contingency Management (CM)
11 Completed Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique
Conditions: HIV;   Syphilis;   Anemia During Pregnancy
Interventions: Device: PIMA® for quantitative analysis of CD4-count;   Device: Hemocue® (HemoCue AB, Angelhom, Sweden) for quantitative analysis of hemoglobin;   Device: SD Bioline® (Standard Diagnostics Inc., South-Korea) for qualitative analysis of syphilis
12 Recruiting The ACCLAIM Project
Condition: HIV
Interventions: Behavioral: Community leader engagement;   Behavioral: Community days;   Behavioral: Community Peer Groups
13 Recruiting ENGAGE4HEALTH: A Combination Intervention Strategy for Linkage and Retention in Mozambique
Condition: HIV
Interventions: Other: Point of care CD4+ after HIV diagnosis;   Other: Accelerated ART initiation;   Behavioral: SMS appointment reminders;   Other: Non-cash Financial Incentives
14 Unknown  Using Implementation Intentions to Increase Safe Sex Practices in MSM
Conditions: HIV;   Sex
Intervention: Behavioral: Planning tasks
15 Active, not recruiting ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)
Conditions: HIV;   Tuberculosis
Interventions: Other: Combination Intervention Package;   Other: Standard of Care
16 Recruiting Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   Tuberculosis
Interventions: Drug: Prednisone;   Drug: Placebo
17 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
18 Recruiting Maternal HIV: Trial to Assist Disclosure to Children
Condition: HIV
Intervention: Behavioral: TRACK Intervention
19 Recruiting A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives
Condition: HIV
Interventions: Behavioral: Prevention & Testing;   Behavioral: Prevention & Testing Control
20 Recruiting Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
Condition: HIV
Intervention: Other: MCH-focused ART services

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years